Hot Features
プレミアム
Idexx Laboratories Inc (IX1)
TG
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. George J. FennellExec. VP of Global CAG Commercial | -284.00 | 160.97k | Derivative Exercise and Sale | 566.79 | 10.43k | - |
| 2026-06-01 | Mr. George J. FennellExec. VP of Global CAG Commercial | 355.00 | 0.00 | Derivative Exercise and Retained Stock | - | 10.43k | 3.52% |
| 2026-05-07 | Mr. Joseph L. HooleyIndependent Director | 158.00 | 0.00 | Derivative Exercise and Retained Stock | - | 276.00 | 133.90% |
| 2026-05-07 | Mr. Daniel M. JuniusIndependent Director | 257.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.56k | 7.78% |
| 2026-05-07 | Ms. Karen A. PeacockIndependent Director | 101.00 | 0.00 | Derivative Exercise and Retained Stock | - | 102.00 | 10,100.00% |
| 2026-05-07 | Mr. Lawrence D. KingsleyIndependent Lead Director | 339.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.57k | 4.12% |
| 2026-05-07 | Ms. M. Anne Szostakインサイダー | 257.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.06k | 14.25% |
| 2026-05-07 | Dr. Sophie V. VandebroekIndependent Director | 257.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.43k | 3.14% |
| 2026-03-03 | Ms. Sharon E. UnderbergExec. VP, General Counsel, & Corporate Secretary | 197.00 | 99.59k | Derivative Exercise and Retained Stock | 505.53 | 7.14k | 2.84% |
| 2026-03-03 | Dr. Nimrata Khatra HuntAdvisor | -1.76k | 1.12M | 売り | 634.57 | 18.30k | -8.76% |
| 2026-02-27 | Mr. Jonathan J. MazelskyExecutive Chairman | 197.00 | 99.59k | Derivative Exercise and Retained Stock | 505.53 | 83.80k | 0.24% |
| 2026-02-26 | Mr. Jonathan J. MazelskyExecutive Chairman | -23.33k | 12.04M | Derivative Exercise and Sale | 141.60 - 663.04 | 83.80k | - |
| 2026-02-26 | Dr. Nimrata Khatra HuntAdvisor | -2.69k | 1.78M | 売り | 661.54 | 20.06k | -11.84% |
| 2026-02-17 | Dr. Sophie V. VandebroekIndependent Director | -945.00 | 278.53k | Derivative Exercise and Sale | 333.90 - 628.65 | 8.17k | - |
| 2026-02-17 | Dr. Sophie V. VandebroekIndependent Director | -519.00 | 326.22k | 売り | 628.56 | 8.17k | -5.97% |
| 2026-02-19 | Mr. Michael G. EricksonCEO, President & Director | 2.40k | 546.56k | Derivative Exercise and Retained Stock | 141.60 - 544.08 | 14.91k | 19.18% |
| 2026-02-17 | Mr. Michael G. EricksonCEO, President & Director | -5.37k | 2.46M | Derivative Exercise and Sale | 141.60 - 629.86 | 14.91k | - |
| 2026-02-14 | Dr. Nimrata Khatra HuntAdvisor | 1.43k | 0.00 | Derivative Exercise and Retained Stock | - | 22.75k | 6.72% |
| 2026-02-14 | Dr. Nimrata Khatra HuntAdvisor | -1.15k | 726.27k | Derivative Exercise and Sale | 629.35 | 22.75k | - |
| 2026-02-14 | Mr. Michael P. JohnsonExec. VP & Chief HR Officer | 395.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.80k | 16.46% |
| 2026-02-14 | Mr. Michael P. JohnsonExec. VP & Chief HR Officer | -178.00 | 112.02k | Derivative Exercise and Sale | 629.35 | 2.80k | - |
| 2026-02-14 | Mr. Michael J. LaneExec. VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology | 871.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.25k | 11.81% |
| 2026-02-14 | Mr. Michael J. LaneExec. VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology | -221.00 | 139.09k | Derivative Exercise and Sale | 629.35 | 8.25k | - |
| 2026-02-14 | Mr. Michael SchreckExec. VP & GM of Veterinary Software and Services, Corporate Accounts and Customer Experience | 1.08k | 0.00 | Derivative Exercise and Retained Stock | - | 3.09k | 53.99% |
| 2026-02-14 | Mr. Michael SchreckExec. VP & GM of Veterinary Software and Services, Corporate Accounts and Customer Experience | -876.00 | 551.31k | Derivative Exercise and Sale | 629.35 | 3.09k | - |
| 2026-02-14 | Mr. Jonathan J. MazelskyExecutive Chairman | 1.14k | 0.00 | Derivative Exercise and Retained Stock | - | 83.61k | 1.38% |
| 2026-02-14 | Mr. Jonathan J. MazelskyExecutive Chairman | -915.00 | 575.86k | Derivative Exercise and Sale | 629.35 | 83.61k | - |
| 2026-02-14 | Ms. Sharon E. UnderbergExec. VP, General Counsel, & Corporate Secretary | 581.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.94k | 9.14% |
| 2026-02-14 | Ms. Sharon E. UnderbergExec. VP, General Counsel, & Corporate Secretary | -251.00 | 157.97k | Derivative Exercise and Sale | 629.35 | 6.94k | - |
| 2026-02-14 | Mr. Martin Alderson Smithインサイダー | 702.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.16k | 48.25% |
| 2026-02-14 | Mr. Martin Alderson Smithインサイダー | -302.00 | 190.06k | Derivative Exercise and Sale | 629.35 | 2.16k | - |
| 2026-02-14 | Mr. George J. FennellExec. VP of Global CAG Commercial | 255.00 | 0.00 | Derivative Exercise and Retained Stock | - | 10.08k | 2.60% |
| 2026-02-14 | Mr. George J. FennellExec. VP of Global CAG Commercial | -199.00 | 125.24k | Derivative Exercise and Sale | 629.35 | 10.08k | - |
| 2026-02-14 | Mr. Andrew EmersonExec. VP, CFO & Treasurer | 333.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.16k | 8.71% |
| 2026-02-14 | Mr. Andrew EmersonExec. VP, CFO & Treasurer | -123.00 | 77.41k | Derivative Exercise and Sale | 629.35 | 4.16k | - |
| 2026-02-09 | Mr. George J. FennellExec. VP of Global CAG Commercial | 1.48k | 100.15k | Derivative Exercise and Retained Stock | 67.85 | 9.82k | 17.68% |
| 2026-02-10 | Mr. George J. FennellExec. VP of Global CAG Commercial | -11.35k | 6.57M | Derivative Exercise and Sale | 67.85 - 650.32 | 9.82k | - |
| 2025-11-07 | Dr. Nimrata Khatra HuntAdvisor | 3.11k | 896.66k | Derivative Exercise and Retained Stock | 288.78 | 21.31k | 17.06% |
| 2025-11-07 | Dr. Nimrata Khatra HuntAdvisor | -9.43k | 2.74M | Derivative Exercise and Sale | 288.78 - 705.54 | 21.31k | - |
| 2025-08-15 | Mr. Jonathan J. MazelskyExecutive Chairman | -1.05k | 0.00 | Other Disposition | - | 82.44k | -1.26% |
| 2025-09-01 | Mr. Martin Alderson Smithインサイダー | 13.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.43k | 0.91% |
| 2025-09-01 | Mr. Martin Alderson Smithインサイダー | -5.00 | 3.24k | Derivative Exercise and Sale | 647.09 | 1.43k | - |
| 2025-08-22 | Ms. M. Anne Szostakインサイダー | -2.19k | 963.82k | Derivative Exercise and Sale | 206.62 - 647.33 | 1.80k | - |
| 2025-08-22 | Ms. M. Anne Szostakインサイダー | -259.00 | 0.00 | Other Disposition | - | 1.80k | -12.55% |
| 2025-08-12 | Mr. Michael G. EricksonCEO, President & Director | -405.89 | 263.81k | 売り | 649.85 - 649.99 | 11.29k | -3.47% |
| 2025-08-12 | Dr. Nimrata Khatra HuntAdvisor | 1.23k | 299.34k | Derivative Exercise and Retained Stock | 178.26 - 544.08 | 18.19k | 7.23% |
| 2025-08-11 | Dr. Nimrata Khatra HuntAdvisor | -1.20k | 787.84k | 売り | 656.53 | 18.19k | -6.19% |
| 2025-08-12 | Ms. Sharon E. UnderbergExec. VP, General Counsel, & Corporate Secretary | 183.00 | 99.57k | Derivative Exercise and Retained Stock | 544.08 | 6.34k | 2.97% |
| 2025-08-08 | Ms. Sharon E. UnderbergExec. VP, General Counsel, & Corporate Secretary | -5.45k | 2.42M | Derivative Exercise and Sale | 206.94 - 651.60 | 6.34k | - |
| 2025-08-08 | Mr. Jonathan J. MazelskyExecutive Chairman | 183.00 | 109.52k | Derivative Exercise and Retained Stock | 598.49 | 83.49k | 0.22% |
| 2025-08-07 | Mr. Andrew EmersonExec. VP, CFO & Treasurer | 1.45k | 204.90k | Derivative Exercise and Retained Stock | 141.60 | 3.87k | 59.69% |
| 2025-08-07 | Mr. Andrew EmersonExec. VP, CFO & Treasurer | -402.00 | 204.40k | Derivative Exercise and Sale | 141.60 - 650.06 | 3.87k | - |
| 2025-08-06 | Dr. Nimrata Khatra HuntAdvisor | 5.65k | 962.70k | Derivative Exercise and Retained Stock | 141.60 - 178.26 | 18.17k | 45.15% |
| 2025-08-06 | Dr. Nimrata Khatra HuntAdvisor | -7.14k | 3.07M | Derivative Exercise and Sale | 178.26 - 630.91 | 18.17k | - |
| 2025-08-06 | Mr. Jonathan J. MazelskyExecutive Chairman | -29.26k | 16.51M | Derivative Exercise and Sale | 67.85 - 639.37 | 83.31k | - |
| 2025-08-06 | Mr. Michael J. LaneExec. VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology | -8.41k | 2.96M | Derivative Exercise and Sale | 206.94 - 628.89 | 7.72k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
